We therefore determined the binding repertoire of PRDM15 in tumoral Eμ-Myc lymphoma cells by performing chromatin immunoprecipitation, followed by next generation sequencing (ChIP-seq) and identified 1327 PRDM15 target sites (Supplementary Data 2). The gene discussed is MYC; the disease is lymphoma.